2399. FDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer.
What is the sensitivity and specificity of 18F-fludeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) imaging for detecting mediastinal lymph node involvement in patients with potentially resectable non-small cell lung cancer (NSCLC)?
|